Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data

scientific article

Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1018796813
P356DOI10.1007/S10545-011-9346-0
P932PMC publication ID3174318
P698PubMed publication ID21556831
P5875ResearchGate publication ID51111981

P2093author name stringFrederick J Marshall
Erika F Augustine
Jonathan W Mink
Heather Adams
Paul G Rothberg
Elisabeth A de Blieck
Jennifer Kwon
Amy Vierhile
Jennifer Cialone
Nicole Newhouse
P2860cites workSpectrum of mutations in the Batten disease gene, CLN3Q24678552
CLN3, the protein associated with batten disease: structure, function and localizationQ28303139
Neuronal ceroid lipofuscinoses in childhoodQ34080022
Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neuronsQ34121060
Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten diseaseQ35216601
Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten diseaseQ35790328
Genetic modulation of apoptotic pathways fails to alter disease course in tripeptidyl-peptidase 1 deficient miceQ37188640
Towards understanding the neuronal ceroid lipofuscinoses.Q37386152
A clinical rating scale for Batten disease: reliable and relevant for clinical trialsQ47613398
Neuronal ceroid lipofuscinosesQ56566989
P433issue5
P921main subjectjuvenile neuronal ceroid lipofuscinosisQ1753778
P304page(s)1075-1081
P577publication date2011-05-10
P1433published inJournal of Inherited Metabolic DiseaseQ6295359
P1476titleParent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data
P478volume34

Reverse relations

cites work (P2860)
Q47826326Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic-ischemic encephalopathy.
Q36986268Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis
Q67231335Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis
Q37659610Clinical trials in rare disease: challenges and opportunities
Q58779774Flupirtine derivatives as potential treatment for the neuronal ceroid lipofuscinoses
Q37021406Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates
Q35840603Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).
Q36556394Reliability and validity of the Wolfram Unified Rating Scale (WURS).

Search more.